Company intelligence / Profile preview

Elidah

Monroe, Connecticut, United Stateselitone.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Elidah has developed and commercialized FDA-cleared, non-invasive wearable devices—Elitone and Elitone URGE—for the treatment of stress and urge urinary incontinence in women. Over 15,000 women have been treated with their products. The technology is supported by clinical research, multiple patents, and has received industry recognition including a CES Innovation Award for Accessibility & Aging Tech[5].

Therapeutic areas
NephrologyWomen's Health
Modalities
DeviceNon-pharmacological therapy
Industry
Therapeutic Medical Devices

Beyond the preview

Go deeper on Elidah.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elidah.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call